Low-dose and high-dose aprotinin improve hemostasis in coronary operations

Journal of Thoracic and Cardiovascular Surgery

Volumn 112, Issue 2, 1996, Pages 523-530

  Speekenbrink, R G H ^a   Wildevuur, C R H ^a   Sturk, A ^a   Eijsman, L ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029783280     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(96)70281-7     Document Type: Article

References (34)

1. W van Oeveren NJG Jansen BP Bidstrup Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass Ann Thorac Surg 44 1987 640 645
2. D Royston KM Taylor BP Bidstrup RN Sapsford Effect of aprotinin on need for blood transfusion after repeat open-heart surgery Lancet 1 1987 1289 1291
3. BP Bidstrup D Royston RN Sapsford Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol) J THORAC CARDIOVASC SURG 97 1989 364 372
4. B Blauhut C Gross S Necek JE Doran P Späth P Lundsgaard-Hansen Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass J THORAC CARDIOVASC SURG 101 1991 958 967
5. W van Oeveren B van Oeveren ChRH Wildevuur Anticoagulation policy during use of aprotinin in cardiopulmonary bypass J THORAC CARDIOVASC SURG 104 1992 210 211
6. P Feindt U Seyfert I Volkmar H Huwer G Kalweit E Gams Is there a phase of hypercoagulability when aprotinin is used in cardiac surgery? Eur J Cardiothorac Surg 8 1994 308 314
7. BP Bidstrup SR Underwood RN Sapsford Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency J THORAC CARDIOVASC SURG 105 1993 147 153
8. ChRH Wildevuur L Eijsman KJ Roozendaal MP Harder M Chang W van Oeveren Platelet preservation during cardiopulmonary bypass with aprotinin Eur J Cardiothorac Surg 3 1989 533 538
9. W van Oeveren MP Harder KJ Roozendaal L Eijsman ChRH Wildevuur Aprotinin protects platelets against the initial effect of cardiopulmonary bypass J THORAC CARDIOVASC SURG 99 1990 788 797
10. M Havel F Grabenwöger J Schneider Aprotinin does not decrease graft patency after coronary bypass grafting despite reducing postoperative bleeding and use of donated blood J THORAC CARDIOVASC SURG 107 1994 807 810
11. T Carrel E Bauer A Laske L von Segesser M Turina Low-dose aprotinin also allows reduction of blood loss after cardiopulmonary bypass J THORAC CARDIOVASC SURG 102 1991 801 802
12. W Müller-Esterl A Oettl E Truscheit H Fritz Monitoring of aprotinin plasma levels by an enzyme-linked immunosorbent assay (ELISA) Fresenius Z Anal Chem 317 1984 718 722
13. MP Harder L Eijsman KJ Roozendaal W van Oeveren ChRH Wildevuur Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator bypass Ann Thorac Surg 51 1991 936 941
14. LH Edmunds S Niewiarowski RW Colman Invited letter concerning aprotinin J THORAC CARDIOVASC SURG 101 1991 1103 1110
15. M Kawasuji K Ueyama N Sakakibara Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary surgery Ann Thorac Surg 55 1993 1205 1209
16. M Spannagl W Dietrich A Beck W Schramm High dose aprotinin reduces prothrombin and fibrinogen conversion in patients undergoing extracorporeal circulation for myocardial revascularization Thromb Haemost 72 1994 159 164
17. H Lu C Soria PL Commin Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol) Thromb Haemost 66 1991 633 637
18. H Huang W Ding Z Su W Zhang Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery J THORAC CARDIOVASC SURG 106 1993 11 18
19. 2 in cultured human umbilical vein endothelial cells J THORAC CARDIOVASC SURG 104 1992 654 658
20. LCH John GM Rees IB Kovacs Reduction of heparin binding to and inhibition of platelets by aprotinin Ann Thorac Surg 55 1993 1175 1179
21. D Royston High-dose aprotinin therapy: a review of the first five years' experience J Cardiothorac Vasc Anesth 6 1992 76 100
22. PA Patston P Gettins J Beechem M Schapira Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate Biochemistry 30 1991 8876 8882
23. Tabuchi N, de Haan J, Boonstra PW, van Oeveren W. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J THORAC CARDIOVASC SURG1993;106:828-33.
24. NJG Jansen W van Oeveren YJ Gu MH van Vliet L Eijsman ChRH Wildevuur Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass Ann Thorac Surg 54 1992 744 748
25. AJ Delrossi AC Cernaianu S Botros GM Lemole R Moore Prophylactic treatment of postperfusion bleeding using epsilon aminocaproic acid Chest 96 1989 27 30
26. Horrow JC, Hlavacek J, Strong MD, et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J THORAC CARDIOVASC SURG1990;99:70-4.
27. 2-plasmin-inhibitor complexes during cardiopulmonary bypass Blood 73 1989 468 471
28. L Eijsman Cardiopulmonary bypass and haemostasis [Thesis] 1992 University of Groningen, The Netherlands 64 73
29. de Smet AAEA, Chang Njoek Joen M, van Oeveren W, et al. Increased anticoagulation during cardiopulmonary bypass by aprotinin. J THORAC CARDIOVASC SURG1990;100:520-7.
30. F Markwardt Hirudin and derivatives as anticoagulant agents Thromb Haemost 66 1991 141 152
31. F España A Estelles JH Griffin J Aznar J Gilabert Aprotinin (Trasylol) is a competitive inhibitor of activated protein C Thromb Res 56 1989 751 756
32. DM Cosgrove B Heric BW Lytle Aprotinin therapy for reoperative myocardial revascularization: a placebo controlled study Ann Thorac Surg 54 1992 1031 1038
33. H Böhrer F Fleischer J Lang C Vahl Early formation of thrombi on pulmonary artery catheters in cardiac surgical patients receiving high-dose aprotinin J Cardiothorac Anesth 4 1990 222 225
34. ChM Samama E Mazoyer P Bruneval Aprotinin could promote arterial thrombosis in pigs: a prospective randomized, blind study Thromb Haemost 71 1994 663 669